-+ 0.00%
-+ 0.00%
-+ 0.00%

COCRYSTAL PHARMA - NO SERIOUS ADVERSE EVENTS REPORTED TO DATE IN CDI-988 PHASE 1B STUDY

路透·09/09/2026 11:00:00

登錄查看新聞詳情